Thursday, June 30, 2016

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

The pathological hallmarks of Alzheimer’s disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this approach still remains valid, it has not yet produced clinically meaningful results.

from Dementia Big http://ift.tt/29dzFvc via alcoholic dementia


http://ift.tt/295OeRX

No comments:

Post a Comment